Biosenta Inc.
ZRO
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.64M | -5.01M | -4.98M | -4.86M | -4.69M |
| Total Depreciation and Amortization | 2.20K | 1.70K | 1.20K | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 859.10K | 4.03M | 3.99M | 3.78M | 3.70M |
| Change in Net Operating Assets | 202.70K | 356.30K | 378.00K | 550.10K | 587.20K |
| Cash from Operations | -573.10K | -626.50K | -604.80K | -531.40K | -408.50K |
| Capital Expenditure | -- | -11.60K | -11.60K | -11.60K | -11.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -11.60K | -11.60K | -11.60K | -11.60K |
| Total Debt Issued | 0.00 | 117.60K | 354.10K | 371.50K | 545.00K |
| Total Debt Repaid | -304.00K | -360.00K | -- | -- | -- |
| Issuance of Common Stock | 1.10M | 1.10M | 500.00K | 500.00K | -- |
| Repurchase of Common Stock | -359.90K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 345.90K | -14.00K | -13.80K | -14.00K | -- |
| Cash from Financing | 574.30K | 620.80K | 620.90K | 633.50K | 404.10K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.10K | -17.20K | 4.70K | 90.70K | -15.80K |
